Anders Anell

Personal Details

First Name:	Anders
Middle Name:
Last Name:	Anell
Suffix:
RePEc Short-ID:	pan558
	[This author has chosen not to make the email address public]

Affiliation

(50%) Företagsekonomiska institutionen
Ekonomihögskolan
Lunds Universitet

Lund, Sweden
http://www.fek.lu.se/
RePEc:edi:felunse (more details at EDIRC)

(50%) Ekonomihögskolan
Lunds Universitet

Lund, Sweden
http://www.ehl.lu.se/
RePEc:edi:ehlunse (more details at EDIRC)

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:

1. Hansen, Fredrik & Anell, Anders & Gerdtham, Ulf-G & Lyttkens, Carl Hampus, 2013. "The Future of Health Economics: The Potential of Behavioral and Experimental Economics," Working Papers 2013:20, Lund University, Department of Economics.

   Mentioned in:

   1. #HEJC papers for August 2013
      by academichealtheconomists in The Academic Health Economists' Blog on 2013-08-01 04:00:48
2. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria, 2015. "Can Pay-for-Performance to Primary Care Providers Stimulate Appropriate Use of Antibiotics?," Working Papers 2015:36, Lund University, Department of Economics, revised 29 Jun 2016.
   • Lina Maria Ellegård & Jens Dietrichson & Anders Anell, 2018. "Can pay‐for‐performance to primary care providers stimulate appropriate use of antibiotics?," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 39-54, January.

   Mentioned in:

   1. Paul Mitchell’s journal round-up for 17th July 2017
      by paulmitchell1 in The Academic Health Economists' Blog on 2017-07-17 16:00:07

Working papers

1. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
   • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2021. "Information, switching costs, and consumer choice: Evidence from two randomised field experiments in Swedish primary health care," Journal of Public Economics, Elsevier, vol. 196(C).

   Cited by:

   1. Anell, Anders & Dackehag, Margareta & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2022. "Better Off by Risk Adjustment? Socioeconomic Disparities in Care Utilization in Sweden Following a Payment Reform," Working Papers 2022:15, Lund University, Department of Economics, revised 12 Mar 2024.
   2. Jens Dietrichson & Lina Maria Ellegård & Gustav Kjellsson, 2020. "Patient choice, entry, and the quality of primary care: Evidence from Swedish reforms," Health Economics, John Wiley & Sons, Ltd., vol. 29(6), pages 716-730, June.
      • Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2016. "Patient Choice, Entry, and the Quality of Primary Care: Evidence from Swedish Reforms," Working Papers 2016:36, Lund University, Department of Economics, revised 27 Jun 2018.
   3. Godager , Geir & Scott, Anthony, 2023. "Physician Behavior and Health Outcomes," HERO Online Working Paper Series 2023:3, University of Oslo, Health Economics Research Programme.
   4. Dahlgren, Cecilia & Dackehag, Margareta & Wändell, Per & Rehnberg, Clas, 2021. "Simply the best? The impact of quality on choice of primary healthcare provider in Sweden," Health Policy, Elsevier, vol. 125(11), pages 1448-1454.
   5. Sveréus, Sofia & Petzold, Max & Rehnberg, Clas, 2024. "Change in avoidable hospitalizations for low-income elders following quasi-market reform in primary care – Evidence from a natural experiment in Sweden," Social Science & Medicine, Elsevier, vol. 346(C).

2. Anell, Anders & Dackehag , Margareta & Dietrichson, Jens, 2016. "Does Risk-Adjusted Payment Influence Primary Care Providers' Decision on Where to Set Up Practices?," Working Papers 2016:24, Lund University, Department of Economics.

   Cited by:

   1. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2021. "Information, switching costs, and consumer choice: Evidence from two randomised field experiments in Swedish primary health care," Journal of Public Economics, Elsevier, vol. 196(C).
      • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
   2. Jens Dietrichson & Lina Maria Ellegård & Gustav Kjellsson, 2020. "Patient choice, entry, and the quality of primary care: Evidence from Swedish reforms," Health Economics, John Wiley & Sons, Ltd., vol. 29(6), pages 716-730, June.
      • Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2016. "Patient Choice, Entry, and the Quality of Primary Care: Evidence from Swedish Reforms," Working Papers 2016:36, Lund University, Department of Economics, revised 27 Jun 2018.

3. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria, 2015. "Can Pay-for-Performance to Primary Care Providers Stimulate Appropriate Use of Antibiotics?," Working Papers 2015:36, Lund University, Department of Economics, revised 29 Jun 2016.
   • Lina Maria Ellegård & Jens Dietrichson & Anders Anell, 2018. "Can pay‐for‐performance to primary care providers stimulate appropriate use of antibiotics?," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 39-54, January.

   Cited by:

   1. Ramerman, Lotte & Hek, Karin & Cramer- van der Welle, Christine & Simons-Winters, Ellis & Middelweerd, Anouk & Lambooij, Anke & Verheij, Robert, 2022. "Incentivizing appropriate prescribing in primary care: Development and first results of an electronic health record-based pay-for-performance scheme," Health Policy, Elsevier, vol. 126(10), pages 1010-1017.
   2. Anell, Anders, 2019. "Performance management and audit & feedback to support learning and innovation – Theoretical review and implications for Swedish primary care," Papers in Innovation Studies 2019/11, Lund University, CIRCLE - Centre for Innovation Research.
   3. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2021. "Information, switching costs, and consumer choice: Evidence from two randomised field experiments in Swedish primary health care," Journal of Public Economics, Elsevier, vol. 196(C).
      • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
   4. Shan Huang & Hannes Ullrich, 2021. "Physician Effects in Antibiotic Prescribing: Evidence from Physician Exits," CESifo Working Paper Series 9204, CESifo.
      • Shan Huang & Hannes Ullrich, 2021. "Physician Effects in Antibiotic Prescribing: Evidence from Physician Exits," Discussion Papers of DIW Berlin 1958, DIW Berlin, German Institute for Economic Research.
   5. Anell, Anders & Dackehag, Margareta & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2022. "Better Off by Risk Adjustment? Socioeconomic Disparities in Care Utilization in Sweden Following a Payment Reform," Working Papers 2022:15, Lund University, Department of Economics, revised 12 Mar 2024.
   6. Lina Maria Ellegård, 2020. "Effects of pay-for-performance on prescription of hypertension drugs among public and private primary care providers in Sweden," International Journal of Health Economics and Management, Springer, vol. 20(3), pages 215-228, September.
      • Ellegård, Lina Maria, 2018. "Effects of Pay-For-Performance on Prescription of Hypertension Drugs among Public and Private Primary Care Providers in Sweden," Working Papers 2018:6, Lund University, Department of Economics.
   7. Blix, Mårten & Jeansson, Johanna, 2018. "Telemedicine and the Welfare State: The Swedish Experience," Working Paper Series 1238, Research Institute of Industrial Economics.
   8. Granlund, David & Zykova, Yana, 2020. "Can privatisation of primary care contribute to the spread of antibiotic resistance?," Umeå Economic Studies 977, Umeå University, Department of Economics.
   9. Shan Huang & Hannes Ullrich, 2023. "Provider effects in antibiotic prescribing: Evidence from physician exits," Berlin School of Economics Discussion Papers 0018, Berlin School of Economics.

Articles

1. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2021. "Information, switching costs, and consumer choice: Evidence from two randomised field experiments in Swedish primary health care," Journal of Public Economics, Elsevier, vol. 196(C).
   • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
   See citations under working paper version above.
2. Lina Maria Ellegård & Jens Dietrichson & Anders Anell, 2018. "Can pay‐for‐performance to primary care providers stimulate appropriate use of antibiotics?," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 39-54, January.
   • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria, 2015. "Can Pay-for-Performance to Primary Care Providers Stimulate Appropriate Use of Antibiotics?," Working Papers 2015:36, Lund University, Department of Economics, revised 29 Jun 2016.
   See citations under working paper version above.
3. Tynkkynen, Liina-Kaisa & Alexandersen, Nina & Kaarbøe, Oddvar & Anell, Anders & Lehto, Juhani & Vrangbӕk, Karsten, 2018. "Development of voluntary private health insurance in Nordic countries – An exploratory study on country-specific contextual factors," Health Policy, Elsevier, vol. 122(5), pages 485-492.

   Cited by:

   1. Purcel, Alexandra-Anca & Dragos, Cristian Mihai & Mare, Codruța & Dragos, Simona Laura, 2023. "Voluntary health insurance and out-of-pocket payments in European OECD countries," Economic Modelling, Elsevier, vol. 120(C).
   2. Aaltonen, Katri & Vaalavuo, Maria, 2024. "Financial burden of medicines in five Northern European countries: A decommodification perspective," Social Science & Medicine, Elsevier, vol. 347(C).
   3. Kullberg, Linn & Blomqvist, Paula & Winblad, Ulrika, 2019. "Health insurance for the healthy? Voluntary health insurance in Sweden," Health Policy, Elsevier, vol. 123(8), pages 737-746.
   4. Lavaste, Konsta, 2023. "Private health insurance in the universal public healthcare system: The role of healthcare provision in Finland," Health Policy, Elsevier, vol. 132(C).
   5. Marenzi, Anna & Rizzi, Dino & Zanette, Michele, 2021. "Incentives for voluntary health insurance in a national health system: Evidence from Italy," Health Policy, Elsevier, vol. 125(6), pages 685-692.
   6. Saunes, Ingrid Sperre & Vrangbæk, Karsten & Byrkjeflot, Haldor & Jervelund, Signe Smith & Birk, Hans Okkels & Tynkkynen, Liina-Kaisa & Keskimäki, Ilmo & Sigurgeirsdóttir, Sigurbjörg & Janlöv, Nils & R, 2022. "Nordic responses to Covid-19: Governance and policy measures in the early phases of the pandemic," Health Policy, Elsevier, vol. 126(5), pages 418-426.

4. Rechel, Bernd & McKee, Martin & Haas, Marion & Marchildon, Gregory P. & Bousquet, Frederic & Blümel, Miriam & Geissler, Alexander & van Ginneken, Ewout & Ashton, Toni & Saunes, Ingrid Sperre & Anell, , 2016. "Public reporting on quality, waiting times and patient experience in 11 high-income countries," Health Policy, Elsevier, vol. 120(4), pages 377-383.

   Cited by:

   1. Emmert, Martin & Kast, Kristina & Sander, Uwe, 2019. "Characteristics and decision making of hospital report card consumers: Lessons from an onsite-based cross-sectional study," Health Policy, Elsevier, vol. 123(11), pages 1061-1067.
   2. Kedai Cheng & Derek S. Young, 2020. "Tolerance intervals for autoregressive models, with an application to hospital waiting lists," Applied Stochastic Models in Business and Industry, John Wiley & Sons, vol. 36(2), pages 268-282, March.
   3. Kelaher, Margaret & Prang, Khic-Houy & Sabanovic, Hana & Dunt, David, 2019. "The impact of public performance reporting on health plan selection and switching: A systematic review and meta-analysis," Health Policy, Elsevier, vol. 123(1), pages 62-70.
   4. Canaway, Rachel & Bismark, Marie & Dunt, David & Prang, Khic-Houy & Kelaher, Margaret, 2018. "“What is meant by public?”: Stakeholder views on strengthening impacts of public reporting of hospital performance data," Social Science & Medicine, Elsevier, vol. 202(C), pages 143-150.
   5. Patricia Kenny & Stephen Goodall & Deborah J. Street & Jessica Greene, 2017. "Choosing a Doctor: Does Presentation Format Affect the Way Consumers Use Health Care Performance Information?," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 10(6), pages 739-751, December.
   6. Samuel Simon, "undated". "Measure Sets and Measurement Systems: Multistakeholder Guidance for Design and Evaluation," Mathematica Policy Research Reports fd565d1f93274407b556c4a28, Mathematica Policy Research.
   7. Jinyang Chen & Chaoqun Wang, 2023. "“The reputation premium”: does hospital ranking improvement lead to a higher healthcare spending?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(5), pages 817-830, July.

5. Smith, Peter C. & Anell, Anders & Busse, Reinhard & Crivelli, Luca & Healy, Judith & Lindahl, Anne Karin & Westert, Gert & Kene, Tobechukwu, 2012. "Leadership and governance in seven developed health systems," Health Policy, Elsevier, vol. 106(1), pages 37-49.

   Cited by:

   1. Changwoo Shon & Myoungsoon You, 2020. "Evaluation of Health Policy Governance in the Introduction of the New DRG-Based Hospital Payment System from Interviews with Policy Elites in South Korea," IJERPH, MDPI, vol. 17(11), pages 1-18, May.
   2. Celia Dana BESCIU, 2013. "Personnel Satisfaction Study regarding the Emergency Medical Services’ Quality of Bucharest Hospitals," REVISTA ADMINISTRATIE SI MANAGEMENT PUBLIC, Faculty of Administration and Public Management, Academy of Economic Studies, Bucharest, Romania, vol. 2013(21), pages 71-83, December.
   3. Glenngård, Anna Häger, 2013. "Productivity and patient satisfaction in primary care—Conflicting or compatible goals?," Health Policy, Elsevier, vol. 111(2), pages 157-165.
   4. Okma, Kieke G.H. & Crivelli, Luca, 2013. "Swiss and Dutch “consumer-driven health care”: Ideal model or reality?," Health Policy, Elsevier, vol. 109(2), pages 105-112.
   5. Klink, Ab & Schakel, H. Christiaan & Visser, Sander & Jeurissen, Patrick, 2017. "The arduous quest for translating health care productivity gains into cost savings. Lessons from their evolution at economic scoring agencies in the Netherlands and the US," Health Policy, Elsevier, vol. 121(1), pages 1-8.
   6. Tello, Juan E. & Barbazza, Erica & Waddell, Kerry, 2020. "Review of 128 quality of care mechanisms: A framework and mapping for health system stewards," Health Policy, Elsevier, vol. 124(1), pages 12-24.
   7. Marmor, Theodore & Wendt, Claus, 2012. "Conceptual frameworks for comparing healthcare politics and policy," Health Policy, Elsevier, vol. 107(1), pages 11-20.

6. Anell, Anders, 2011. "Choice and privatisation in Swedish primary care," Health Economics, Policy and Law, Cambridge University Press, vol. 6(4), pages 549-569, October.

   Cited by:

   1. Lina Maria Ellegård & Jens Dietrichson & Anders Anell, 2018. "Can pay‐for‐performance to primary care providers stimulate appropriate use of antibiotics?," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 39-54, January.
      • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria, 2015. "Can Pay-for-Performance to Primary Care Providers Stimulate Appropriate Use of Antibiotics?," Working Papers 2015:36, Lund University, Department of Economics, revised 29 Jun 2016.
   2. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2021. "Information, switching costs, and consumer choice: Evidence from two randomised field experiments in Swedish primary health care," Journal of Public Economics, Elsevier, vol. 196(C).
      • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
   3. Glenngård, Anna Häger, 2013. "Productivity and patient satisfaction in primary care—Conflicting or compatible goals?," Health Policy, Elsevier, vol. 111(2), pages 157-165.
   4. Anell, Anders & Dackehag , Margareta & Dietrichson, Jens, 2016. "Does Risk-Adjusted Payment Influence Primary Care Providers' Decision on Where to Set Up Practices?," Working Papers 2016:24, Lund University, Department of Economics.
   5. Vengberg, Sofie & Fredriksson, Mio & Winblad, Ulrika, 2019. "Patient choice and provider competition – Quality enhancing drivers in primary care?," Social Science & Medicine, Elsevier, vol. 226(C), pages 217-224.
   6. Sveréus, Sofia & Kjellsson, Gustav & Rehnberg, Clas, 2018. "Socioeconomic distribution of GP visits following patient choice reform and differences in reimbursement models: Evidence from Sweden," Health Policy, Elsevier, vol. 122(9), pages 949-956.
   7. Granlund, David & Zykova, Yana, 2020. "Can privatisation of primary care contribute to the spread of antibiotic resistance?," Umeå Economic Studies 977, Umeå University, Department of Economics.
   8. Dahlgren, Cecilia & Dackehag, Margareta & Wändell, Per & Rehnberg, Clas, 2021. "Simply the best? The impact of quality on choice of primary healthcare provider in Sweden," Health Policy, Elsevier, vol. 125(11), pages 1448-1454.
   9. Lapidus, John, 2017. "Private health insurance in Sweden: Fast-track lanes and the alleged attempts to stop them," Health Policy, Elsevier, vol. 121(4), pages 442-449.
   10. Björn Ekman & Jens Wilkens, 2015. "A literature review of the regional implementation of the central Swedish government’s health care reforms on choice and privatization," Health Economics Review, Springer, vol. 5(1), pages 1-5, December.

7. Glenngård, Anna H. & Anell, Anders & Beckman, Anders, 2011. "Choice of primary care provider: Results from a population survey in three Swedish counties," Health Policy, Elsevier, vol. 103(1), pages 31-37.

   Cited by:

   1. Jeannette Brosig‐Koch & Burkhard Hehenkamp & Johanna Kokot, 2023. "Who benefits from quality competition in health care? A theory and a laboratory experiment on the relevance of patient characteristics," Health Economics, John Wiley & Sons, Ltd., vol. 32(8), pages 1785-1817, August.
      • Brosig-Koch, Jeannette & Hehenkamp, Burkhard & Kokot, Johanna, 2022. "Who benefits from quality competition in health care? A theory and a laboratory experiment on the relevance of patient characteristics," hche Research Papers 27, University of Hamburg, Hamburg Center for Health Economics (hche).
   2. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2021. "Information, switching costs, and consumer choice: Evidence from two randomised field experiments in Swedish primary health care," Journal of Public Economics, Elsevier, vol. 196(C).
      • Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
   3. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2022. "Well-Informed Choices? Effects of Information Interventions in Primary Care on Care Quality," Working Papers 2022:2, Lund University, Department of Economics.
   4. Stéphanie Jamet & Thomas Chalaux & Vincent Koen, 2013. "Labour Market and Social Policies to Foster More Inclusive Growth in Sweden," OECD Economics Department Working Papers 1023, OECD Publishing.
   5. Jens Dietrichson & Lina Maria Ellegård & Gustav Kjellsson, 2020. "Patient choice, entry, and the quality of primary care: Evidence from Swedish reforms," Health Economics, John Wiley & Sons, Ltd., vol. 29(6), pages 716-730, June.
      • Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2016. "Patient Choice, Entry, and the Quality of Primary Care: Evidence from Swedish Reforms," Working Papers 2016:36, Lund University, Department of Economics, revised 27 Jun 2018.
   6. Glenngård, Anna Häger, 2013. "Productivity and patient satisfaction in primary care—Conflicting or compatible goals?," Health Policy, Elsevier, vol. 111(2), pages 157-165.
   7. Vengberg, Sofie & Fredriksson, Mio & Winblad, Ulrika, 2019. "Patient choice and provider competition – Quality enhancing drivers in primary care?," Social Science & Medicine, Elsevier, vol. 226(C), pages 217-224.
   8. Sveréus, Sofia & Kjellsson, Gustav & Rehnberg, Clas, 2018. "Socioeconomic distribution of GP visits following patient choice reform and differences in reimbursement models: Evidence from Sweden," Health Policy, Elsevier, vol. 122(9), pages 949-956.
   9. Dahlgren, Cecilia & Dackehag, Margareta & Wändell, Per & Rehnberg, Clas, 2021. "Simply the best? The impact of quality on choice of primary healthcare provider in Sweden," Health Policy, Elsevier, vol. 125(11), pages 1448-1454.
   10. Fernández-Pérez, A.; & Jiménez-Rubio, D.; & Robone, S.;, 2019. "The Effect of Freedom of Choice on Health System Responsiveness. Evidence from Spain," Health, Econometrics and Data Group (HEDG) Working Papers 19/21, HEDG, c/o Department of Economics, University of York.
   11. Björn Ekman & Jens Wilkens, 2015. "A literature review of the regional implementation of the central Swedish government’s health care reforms on choice and privatization," Health Economics Review, Springer, vol. 5(1), pages 1-5, December.
   12. Sixten Borg & Bo Palaszewski & Ulf-G Gerdtham & Ödegaard Fredrik & Pontus Roos & Soffia Gudbjörnsdottir, 2014. "Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden," IJERPH, MDPI, vol. 11(12), pages 1-24, November.

8. Hjelmgren, Jonas & Anell, Anders, 2007. "Population preferences and choice of primary care models: A discrete choice experiment in Sweden," Health Policy, Elsevier, vol. 83(2-3), pages 314-322, October.

   Cited by:

   1. Andriy Danyliv & Milena Pavlova & Irena Gryga & Wim Groot, 2015. "Preferences for physician services in Ukraine: a discrete choice experiment," International Journal of Health Planning and Management, Wiley Blackwell, vol. 30(4), pages 346-365, October.
   2. Ratcliffe, Julie & Bekker, Hilary L. & Dolan, Paul & Edlin, Richard, 2009. "Examining the attitudes and preferences of health care decision-makers in relation to access, equity and cost-effectiveness: A discrete choice experiment," Health Policy, Elsevier, vol. 90(1), pages 45-57, April.
   3. Glenngård, Anna H. & Anell, Anders & Beckman, Anders, 2011. "Choice of primary care provider: Results from a population survey in three Swedish counties," Health Policy, Elsevier, vol. 103(1), pages 31-37.
   4. Phoebe Koundouri & Yannis Kountouris & Mavra Stithou, 2012. "A Choice Experiments Application in Transport Infrastructure: A Case Study on Travel Time Savings, Accidents and Pollution Reduction," DEOS Working Papers 1227, Athens University of Economics and Business.
      • Koundouri, Phoebe & Kountouris, Yannis & Stithou, Mavra, 2012. "A Choice Experiments Application in Transport Infrastructure: A Case Study on Travel Time Savings, Accidents and Pollution Reduction," MPRA Paper 38274, University Library of Munich, Germany.
      • Marva Stithou & Yiannis Kountouris & Phoebe Koundouri, 2011. "A Choice Experiments Application in Transport Infrastructure: A case study on travel time savings, accidents and pollution reduction," DEOS Working Papers 1116, Athens University of Economics and Business.
   5. Chiara Seghieri & Alessandro Mengoni & Sabina Nuti, 2014. "Applying discrete choice modelling in a priority setting: an investigation of public preferences for primary care models," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(7), pages 773-785, September.
   6. Pedersen, Line Bjørnskov & Hess, Stephane & Kjær, Trine, 2016. "Asymmetric information and user orientation in general practice: Exploring the agency relationship in a best–worst scaling study," Journal of Health Economics, Elsevier, vol. 50(C), pages 115-130.
   7. Gao, Ya & Pan, Haixiao & Xie, Zhilin & Habib, Khandker Nurul, 2023. "Understanding patients heterogeneity in healthcare travel and hospital choice - A latent class analysis with covariates," Journal of Transport Geography, Elsevier, vol. 110(C).
   8. Qian Zhao & Miles M Yang & Yu-Ying Huang & Wenlin Chen, 2018. "How to make hand hygiene interventions more attractive to nurses: A discrete choice experiment," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-11, August.
   9. Ahgren, Bengt, 2010. "Competition and integration in Swedish health care," Health Policy, Elsevier, vol. 96(2), pages 91-97, July.
   10. Mesfin G. Genie & Mandy Ryan & Nicolas Krucien, 2023. "Keeping an eye on cost: What can eye tracking tell us about attention to cost information in discrete choice experiments?," Health Economics, John Wiley & Sons, Ltd., vol. 32(5), pages 1101-1119, May.
   11. Kehinde, M. O. & Shittu, A. M. & Osunsina, I. O. O., 2019. "Willingness to Accept Incentives for a Shift to Climate-Smart Agriculture among Lowland Rice Farmers in Nigeria," Nigerian Journal of Agricultural Economics, Nigerian Journal of Agricultural Economics, vol. 9(1), October.
   12. Michael P. Keane & Nada Wasi, 2013. "The Structure of Consumer Taste Heterogeneity in Revealed vs. Stated Preference Data," Economics Papers 2013-W10, Economics Group, Nuffield College, University of Oxford.
   13. Paul Scuffham & Jennifer Whitty & Matthew Taylor & Ruth Saxby, 2010. "Health system choice," Applied Health Economics and Health Policy, Springer, vol. 8(2), pages 89-97, March.
   14. Schuldt, Johannes & Doktor, Anna & Lichters, Marcel & Vogt, Bodo & Robra, Bernt-Peter, 2017. "Insurees’ preferences in hospital choice—A population-based study," Health Policy, Elsevier, vol. 121(10), pages 1040-1046.
   15. Shittu, A. & Kehinde, M., 2018. "Willingness to Accept Incentives for a Shift to Climate – Smart Agriculture among Smallholder Farmers in Southwest and Northcentral Nigeria," 2018 Conference, July 28-August 2, 2018, Vancouver, British Columbia 275983, International Association of Agricultural Economists.
   16. Philips, Hilde & Mahr, Dominik & Remmen, Roy & Weverbergh, Marcel & De Graeve, Diana & Van Royen, Paul, 2012. "Predicting the place of out-of-hours care—A market simulation based on discrete choice analysis," Health Policy, Elsevier, vol. 106(3), pages 284-290.

9. Jansson, Sandra & Anell, Anders, 2006. "The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness," Health Policy, Elsevier, vol. 76(3), pages 299-311, May.

   Cited by:

   1. Gregory Merlo & Katie Page & Julie Ratcliffe & Kate Halton & Nicholas Graves, 2015. "Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 303-309, June.
   2. Katharina Elisabeth Fischer & Taika Koch & Karel Kostev & Tom Stargardt, 2018. "The impact of physician-level drug budgets on prescribing behavior," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(2), pages 213-222, March.

10. Anders Anell & Ulf Persson, 2005. "Reimbursement and clinical guidance for pharmaceuticals in Sweden," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 274-279, September.

    Cited by:

    1. Simon Walker & Mark Sculpher & Karl Claxton & Steve Palmer, 2012. "Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions," Working Papers 077cherp, Centre for Health Economics, University of York.
    2. Brian Godman & Lars Gustafsson, 2013. "A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing," Applied Health Economics and Health Policy, Springer, vol. 11(1), pages 79-82, February.
    3. Mikael Svensson & Fredrik Nilsson & Karl Arnberg, 2015. "Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness," PharmacoEconomics, Springer, vol. 33(11), pages 1229-1236, November.
    4. David Granlund & Miyase Koksal-Ayhan, 2015. "Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(9), pages 969-983, December.
    5. Hultkrantz, Lars & Svensson, Mikael, 2012. "A Comparison of Benefit Cost and Cost Utility Analysis in Practice: Divergent Policies in Sweden," Working Papers 2012:5, Örebro University, School of Business.
       • Hultkrantz, Lars & Svensson, Mikael, 2012. "A Comparison of Benefit Cost and Cost Utility Analysis in Practice: Divergent Policies in Sweden," Karlstad University Working Papers in Economics 1, Karlstad University, Department of Economics.
    6. Carlson, Josh J. & Sullivan, Sean D. & Garrison, Louis P. & Neumann, Peter J. & Veenstra, David L., 2010. "Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers," Health Policy, Elsevier, vol. 96(3), pages 179-190, August.
    7. Granlund, David & Köksal, Miyase Yesim, 2011. "Parallel Imports and Mandatory Substitution Reform - A Kick or A Muff for Price Competition in Pharmaceuticals?," HUI Working Papers 49, HUI Research.
    8. Adrian Levy & Craig Mitton & Karissa Johnston & Brian Harrigan & Andrew Briggs, 2010. "International Comparison of Comparative Effectiveness Research in Five Jurisdictions," PharmacoEconomics, Springer, vol. 28(10), pages 813-830, October.
    9. Michael Drummond, 2012. "Twenty Years of Using Economic Evaluations for Reimbursement Decisions. What Have We Achieved?," Working Papers 075cherp, Centre for Health Economics, University of York.
    10. Tania Stafinski & Devidas Menon & Deborah Marshall & Timothy Caulfield, 2011. "Societal Values in the Allocation of Healthcare Resources," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 4(4), pages 207-225, December.
    11. Wasem, Jürgen & Weegen, Lennart & Bauer, Cosima & Walendzik, Anke & Grande, Frederic & May, Uwe, 2015. "Regulatorische Handhabung der selektiven Erstattung von Arzneimitteln in den ausgewählten Ländern England, Niederlande, Frankreich und Schweden," IBES Diskussionsbeiträge 211, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    12. Lianne Barnieh & Fiona Clement & Anthony Harris & Marja Blom & Cam Donaldson & Scott Klarenbach & Don Husereau & Diane Lorenzetti & Braden Manns, 2014. "A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-10, March.
    13. Ulf Persson & Johanna Svensson & Billie Pettersson, 2012. "A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing," Applied Health Economics and Health Policy, Springer, vol. 10(4), pages 217-225, July.
    14. Granlund, David & Yesim Köksal, Miyase, 2011. "Parallel Imports and Mandatory Substitution Reform: A kick or a muff for price competition in pharmaceuticals," Working Papers in Economics 496, University of Gothenburg, Department of Economics.

11. Anell, Anders, 2005. "Deregulating the pharmacy market: the case of Iceland and Norway," Health Policy, Elsevier, vol. 75(1), pages 9-17, December.

    Cited by:

    1. Bruno, Giuseppe & Cavola, Manuel & Diglio, Antonio & Elizalde, Javier & Piccolo, Carmela, 2022. "A locational analysis of deregulation policies in the Spanish retail pharmaceutical sector," Socio-Economic Planning Sciences, Elsevier, vol. 82(PA).
    2. Jo, Wooyong & Nam, Hyoryung & Choi, Jeonghye, 2022. "Opening the OTC drug market: The effect of deregulation on retail pharmacy’s performance," International Journal of Research in Marketing, Elsevier, vol. 39(3), pages 847-866.
    3. Moura, Ana, 2021. "Essays in health economics," Other publications TiSEM c93abd22-fa4a-42a5-b172-d, Tilburg University, School of Economics and Management.
    4. Lluch, Maria & Kanavos, Panos, 2010. "Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain," Health Policy, Elsevier, vol. 95(2-3), pages 245-254, May.
    5. Ana Moura & Pedro Pita Barros, 2020. "Entry and price competition in the over‐the‐counter drug market after deregulation: Evidence from Portugal," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 865-877, August.
    6. Gallone, Emma Luisa & Ravetto Enri, Lorenzo & Pignata, Irene & Baratta, Francesca & Brusa, Paola, 2020. "The 2017 deregulation of pharmacies in Italy: Introducing non-pharmacist ownership," Health Policy, Elsevier, vol. 124(12), pages 1281-1286.
    7. Guhl, Dennis & Stargardt, Tom & Schneider, Udo & Fischer, Katharina E., 2016. "Dispensing behaviour of pharmacies in prescription drug markets," Health Policy, Elsevier, vol. 120(2), pages 190-197.
    8. Martins, Lurdes & Queirós, Sónia, 2015. "Competition among pharmacies and the typology of services delivered: The Portuguese case," Health Policy, Elsevier, vol. 119(5), pages 640-647.
    9. Barbarisi, Ilaria & Bruno, Giuseppe & Diglio, Antonio & Elizalde, Javier & Piccolo, Carmela, 2019. "A spatial analysis to evaluate the impact of deregulation policies in the pharmacy sector: Evidence from the case of Navarre," Health Policy, Elsevier, vol. 123(11), pages 1108-1115.
    10. Wisell, Kristin & Winblad, Ulrika & Kälvemark Sporrong, Sofia, 2019. "Diversity as salvation? – A comparison of the diversity rationale in the Swedish pharmacy ownership liberalization reform and the primary care choice reform," Health Policy, Elsevier, vol. 123(5), pages 457-461.
    11. Vogler, Sabine & Habimana, Katharina & Arts, Danielle, 2014. "Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries," Health Policy, Elsevier, vol. 117(3), pages 311-327.
    12. Stargardt, Tom & Schreyögg, Jonas & Busse, Reinhard, 2007. "Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany," Health Policy, Elsevier, vol. 84(1), pages 30-38, November.
    13. Andrea Cintolesi & Andrea Riganti, 2022. "Liberalizing the opening of new pharmacies and hospitalizations," Temi di discussione (Economic working papers) 1388, Bank of Italy, Economic Research and International Relations Area.
    14. Håkonsen, Helle & Sundell, Karolina Andersson & Martinsson, Johan & Hedenrud, Tove, 2016. "Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market," Health Policy, Elsevier, vol. 120(3), pages 327-333.
    15. Håkonsen, Helle & Horn, Anne Marie & Toverud, Else-Lydia, 2009. "Price control as a strategy for pharmaceutical cost containment--What has been achieved in Norway in the period 1994-2004?," Health Policy, Elsevier, vol. 90(2-3), pages 277-285, May.
    16. Eva Jansson, 0. "Deregulation, property rights, and legal system," European Journal of Law and Economics, Springer, vol. 0, pages 1-25.

12. Anders Anell, 2005. "Swedish healthcare under pressure," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 237-254, September.

    Cited by:

    1. Stefan Meyer, 2015. "Payment schemes and cost efficiency: evidence from Swiss public hospitals," International Journal of Health Economics and Management, Springer, vol. 15(1), pages 73-97, March.
    2. Hjelmgren, Jonas & Anell, Anders, 2007. "Population preferences and choice of primary care models: A discrete choice experiment in Sweden," Health Policy, Elsevier, vol. 83(2-3), pages 314-322, October.
    3. Toth, Federico, 2010. "Healthcare policies over the last 20 years: Reforms and counter-reforms," Health Policy, Elsevier, vol. 95(1), pages 82-89, April.
    4. d'Andria, Diego, 2008. "The Debate on the Sustainability of Social Spending," MPRA Paper 11745, University Library of Munich, Germany.
    5. Ulf-G Gerdtham & Philip Clarke & Alison Hayes & Soffia Gudbjornsdottir, 2009. "Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data," PharmacoEconomics, Springer, vol. 27(1), pages 81-90, January.
    6. Kristian Bolin & Anna Lindgren & Björn Lindgren & Petter Lundborg, 2009. "Utilisation of physician services in the 50+ population: the relative importance of individual versus institutional factors in 10 European countries," International Journal of Health Economics and Management, Springer, vol. 9(1), pages 83-112, March.
       • Kristian Bolin & Anna Lindgren & Bjorn Lindgren & Petter Lundborg, 2008. "Utilisation of Physician Services in the 50+ Population. The Relative Importance of Individual versus Institutional Factors in 10 European Countries," NBER Working Papers 14096, National Bureau of Economic Research, Inc.
    7. Samantha Smith, 2010. "The Irish ‘health basket’: a basket case?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(3), pages 343-350, June.
    8. Joan Costa-Font & Valentina Zigante, 2016. "The choice agenda in European health systems: the role of middle-class demands," Public Money & Management, Taylor & Francis Journals, vol. 36(6), pages 409-416, September.
    9. Cecilia Gardsten & Kerstin Blomqvist & Mikael Rask & Åse Larsson & Agneta Lindberg & Gith Olsson, 2018. "Challenges in everyday life among recently diagnosed and more experienced adults with type 2 diabetes: A multistage focus group study," Journal of Clinical Nursing, John Wiley & Sons, vol. 27(19-20), pages 3666-3678, October.
    10. Wettermark, Björn & Godman, Brian & Neovius, Martin & Hedberg, Niklas & Mellgren, Tor-Olov & Kahan, Thomas, 2010. "Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment," Health Policy, Elsevier, vol. 94(3), pages 221-229, March.
    11. Joan Costa-i-Font & Valentina Zigante, 2014. "The Choice Agenda' in European Health Systems: The Role of 'Middle Class Demands," LEQS – LSE 'Europe in Question' Discussion Paper Series 82, European Institute, LSE.

13. Anders Anell, 2004. "Priority setting for pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(1), pages 28-35, February.

    Cited by:

    1. Morgan, Steve & McMahon, Meghan & Greyson, Devon, 2008. "Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia," Health Policy, Elsevier, vol. 87(2), pages 133-145, August.
    2. Gregory Merlo & Katie Page & Pauline Zardo & Nicholas Graves, 2019. "Applying an Implementation Framework to the Use of Evidence from Economic Evaluations in Making Healthcare Decisions," Applied Health Economics and Health Policy, Springer, vol. 17(4), pages 533-543, August.
    3. Gregory Merlo & Katie Page & Julie Ratcliffe & Kate Halton & Nicholas Graves, 2015. "Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 303-309, June.
    4. Fischer, Katharina E. & Leidl, Reiner & Rogowski, Wolf H., 2011. "A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention," Health Policy, Elsevier, vol. 101(3), pages 290-299, August.
    5. Amani Thomas Mori & Eliangiringa Amos Kaale & Frida Ngalesoni & Ole Frithjof Norheim & Bjarne Robberstad, 2014. "The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-10, January.
    6. Anders Anell & Ulf Persson, 2005. "Reimbursement and clinical guidance for pharmaceuticals in Sweden," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 274-279, September.
    7. Greß, Stefan & Klaucke, Lena & Kötting, Cosima & May, Uwe & Wasem, Jürgen, 2008. "Preisregulierung von verschreibungspflichtigen Arzneimitteln in der gesetzlichen Krankenversicherung nach dem GKV-Wettbewerbsstärkungsgesetz," IBES Diskussionsbeiträge 170, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    8. Aris Angelis & Ansgar Lange & Panos Kanavos, 2018. "Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 123-152, January.
    9. Katharina Fischer & Reiner Leidl, 2014. "Analysing coverage decision-making: opening Pandora’s box?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 899-906, December.
    10. Margreet Franken & Fredrik Nilsson & Frank Sandmann & Anthonius Boer & Marc Koopmanschap, 2013. "Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making," PharmacoEconomics, Springer, vol. 31(9), pages 781-797, September.
    11. Fischer, Katharina Elisabeth, 2012. "A systematic review of coverage decision-making on health technologies—Evidence from the real world," Health Policy, Elsevier, vol. 107(2), pages 218-230.

14. Rosen, Per & Anell, Anders & Hjortsberg, Catharina, 2001. "Patient views on choice and participation in primary health care," Health Policy, Elsevier, vol. 55(2), pages 121-128, February.

    Cited by:

    1. Glenngård, Anna H. & Anell, Anders & Beckman, Anders, 2011. "Choice of primary care provider: Results from a population survey in three Swedish counties," Health Policy, Elsevier, vol. 103(1), pages 31-37.
    2. Malcom Hopwood, 2020. "The Shared Decision-Making Process in the Pharmacological Management of Depression," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 13(1), pages 23-30, February.
    3. Hjelmgren, Jonas & Anell, Anders, 2007. "Population preferences and choice of primary care models: A discrete choice experiment in Sweden," Health Policy, Elsevier, vol. 83(2-3), pages 314-322, October.
    4. Ahgren, Bengt, 2010. "Competition and integration in Swedish health care," Health Policy, Elsevier, vol. 96(2), pages 91-97, July.
    5. Lim, Jennifer N.W. & Edlin, Richard, 2009. "Preferences of older patients and choice of treatment location in the UK: A binary choice experiment," Health Policy, Elsevier, vol. 91(3), pages 252-257, August.
    6. Jonsson, Pia Maria & Schmidt, Ingrid & Sparring, Vibeke & Tomson, Goran, 2006. "Gender equity in health care in Sweden--Minor improvements since the 1990s," Health Policy, Elsevier, vol. 77(1), pages 24-36, June.
    7. Meinow, Bettina & Parker, Marti G. & Thorslund, Mats, 2011. "Consumers of eldercare in Sweden: The semblance of choice," Social Science & Medicine, Elsevier, vol. 73(9), pages 1285-1289.

15. Anell, Anders & Norinder, Anna, 2000. "Health outcome measures used in cost-effectiveness studies: a review of original articles published between 1986 and 1996," Health Policy, Elsevier, vol. 51(2), pages 87-99, March.

    Cited by:

    1. Béranger Lueza & Audrey Mauguen & Jean-Pierre Pignon & Oliver Rivero-Arias & Julia Bonastre & MAR-LC Collaborative Group, 2016. "Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study," PLOS ONE, Public Library of Science, vol. 11(3), pages 1-12, March.
    2. Maria-Florencia Hutter & Roberto Rodríguez-Ibeas & Fernando Antonanzas, 2014. "Methodological reviews of economic evaluations in health care: what do they target?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(8), pages 829-840, November.

16. Anell, Anders & Rosen, Per & Hjortsberg, Catharina, 1997. "Choice and participation in the health services: a survey of preferences among swedish residents," Health Policy, Elsevier, vol. 40(2), pages 157-168, May.

    Cited by:

    1. Glenngård, Anna H. & Anell, Anders & Beckman, Anders, 2011. "Choice of primary care provider: Results from a population survey in three Swedish counties," Health Policy, Elsevier, vol. 103(1), pages 31-37.
    2. Hjelmgren, Jonas & Anell, Anders, 2007. "Population preferences and choice of primary care models: A discrete choice experiment in Sweden," Health Policy, Elsevier, vol. 83(2-3), pages 314-322, October.
    3. Calltorp, Johan, 1999. "Priority setting in health policy in Sweden and a comparison with Norway," Health Policy, Elsevier, vol. 50(1-2), pages 1-22, December.
    4. Rosen, Per & Anell, Anders & Hjortsberg, Catharina, 2001. "Patient views on choice and participation in primary health care," Health Policy, Elsevier, vol. 55(2), pages 121-128, February.
    5. Lim, Jennifer N.W. & Edlin, Richard, 2009. "Preferences of older patients and choice of treatment location in the UK: A binary choice experiment," Health Policy, Elsevier, vol. 91(3), pages 252-257, August.
    6. Jonsson, Pia Maria & Schmidt, Ingrid & Sparring, Vibeke & Tomson, Goran, 2006. "Gender equity in health care in Sweden--Minor improvements since the 1990s," Health Policy, Elsevier, vol. 77(1), pages 24-36, June.

17. Anell, Anders, 1996. "The monopolistic integrated model and health care reform: the Swedish experience," Health Policy, Elsevier, vol. 37(1), pages 19-33, July.

    Cited by:

    1. Glenngård, Anna H. & Anell, Anders & Beckman, Anders, 2011. "Choice of primary care provider: Results from a population survey in three Swedish counties," Health Policy, Elsevier, vol. 103(1), pages 31-37.
    2. Harrison, Michael I. & Calltorp, Johan, 2000. "The reorientation of market-oriented reforms in Swedish health-care," Health Policy, Elsevier, vol. 50(3), pages 219-240, January.
    3. Anders Anell, 2005. "Swedish healthcare under pressure," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 237-254, September.
    4. Karlsson, Martin, 2007. "Quality incentives for GPs in a regulated market," Journal of Health Economics, Elsevier, vol. 26(4), pages 699-720, July.
    5. Jegers, Marc & Kesteloot, Katrien & De Graeve, Diana & Gilles, Willem, 2002. "A typology for provider payment systems in health care," Health Policy, Elsevier, vol. 60(3), pages 255-273, June.
    6. Mikkola, Hennamari & Keskimaki, Ilmo & Hakkinen, Unto, 2002. "DRG-related prices applied in a public health care system--can Finland learn from Norway and Sweden?," Health Policy, Elsevier, vol. 59(1), pages 37-51, January.
    7. Hussey, P. & Anderson, G. F., 2003. "A comparison of single- and multi-payer health insurance systems and options for reform," Health Policy, Elsevier, vol. 66(3), pages 215-228, December.
    8. Larizgoitia, Itziar & Starfield, Barbara, 1997. "Reform of primary health care: the case of Spain," Health Policy, Elsevier, vol. 41(2), pages 121-137, August.
    9. Lim, Jennifer N.W. & Edlin, Richard, 2009. "Preferences of older patients and choice of treatment location in the UK: A binary choice experiment," Health Policy, Elsevier, vol. 91(3), pages 252-257, August.
    10. Serden, Lisbeth & Lindqvist, Rikard & Rosen, Mans, 2003. "Have DRG-based prospective payment systems influenced the number of secondary diagnoses in health care administrative data?," Health Policy, Elsevier, vol. 65(2), pages 101-107, August.
    11. Garpenby, Peter, 1997. "Implementing quality programmes in three Swedish county councils: the views of politicians, managers and doctors," Health Policy, Elsevier, vol. 39(3), pages 195-206, March.
    12. Vining, Aidan R. & Globerman, Steven, 1999. "Contracting-out health care services: a conceptual framework," Health Policy, Elsevier, vol. 46(2), pages 77-96, January.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 6 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.

1. NEP-HEA: Health Economics (4) 2013-07-15 2015-12-28 2017-05-21 2022-02-14
2. NEP-EUR: Microeconomic European Issues (2) 2022-02-14 2022-09-26
3. NEP-EXP: Experimental Economics (2) 2013-07-15 2017-05-21
4. NEP-CBE: Cognitive and Behavioural Economics (1) 2013-07-15
5. NEP-HIS: Business, Economic and Financial History (1) 2022-02-14
6. NEP-HRM: Human Capital and Human Resource Management (1) 2019-07-29
7. NEP-ICT: Information and Communication Technologies (1) 2017-05-21
8. NEP-MKT: Marketing (1) 2017-05-21

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Anders Anell should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.